Skip to content

HOPE Intervention for COVID-19

Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04376515
Enrollment
120
Registered
2020-05-06
Start date
2021-07-23
Completion date
2021-09-30
Last updated
2025-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Vaccination

Brief summary

The Harnessing Online Peer Education COVID-19 (HOPE COVID-19) intervention will assess whether a peer-led online support community can improve behavioral health outcomes related to COVID-19.

Detailed description

The Harnessing Online Peer Education COVID-19 (HOPE COVID-19) intervention will assess whether a peer-led online support community can improve behavioral health outcomes related to COVID-19. Participants in the intervention group will be assigned to peer leaders trained in the HOPE intervention methods.

Interventions

Online peer support community of peers trained in behavior change science

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. 18-30 years old 2. English speakers only 3. U.S. Resident 4. Part of phase 1a or 1b of COVID-19 vaccine rollout (Healthcare personnel, education, and frontline essential workers, verified through LinkedIn profile) 5. Uses social media and/or online communities greater than twice per week 6. Has, or is willing to accept a friend request and group invite from our Facebook social media page 7. Have not received a COVID-19 vaccine and do not have medical conditions or other circumstances preventing them from receiving one

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Requests for a COVID-19 Vaccine Resource Sheet1 time request during the 4-week studyWhether or not the participant requested that our study team send them an electronic resource sheet on the COVID-19 vaccine and where they can get vaccinated.

Secondary

MeasureTime frameDescription
Proof of COVID-19 Vaccination1 time proof during 4-week study and up to 2 weeks afterWhether or not a participant sent us a proof of a COVID-19 Vaccination

Countries

United States

Participant flow

Recruitment details

Participants (N = 120) were recruited through online advertisements from July 23 to August 20, 2021.

Participants by arm

ArmCount
HOPE Intervention
HOPE peer-led intervention HOPE intervention: Online peer support community of peers trained in behavior change science
54
Control
Control group- online community without peer leaders
54
Total108

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyFound to have been vaccinated before study start66

Baseline characteristics

CharacteristicHOPE InterventionControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants0 Participants1 Participants
Age, Categorical
Between 18 and 65 years
53 Participants54 Participants107 Participants
Age, Continuous39.94 years
STANDARD_DEVIATION 10.15
38.09 years
STANDARD_DEVIATION 11.63
39.02 years
STANDARD_DEVIATION 10.9
COVID-19 Vaccination Status: Unvaccinated54 Participants54 Participants108 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants11 Participants20 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
45 Participants39 Participants84 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants4 Participants4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
3 Participants4 Participants7 Participants
Race (NIH/OMB)
Asian
2 Participants2 Participants4 Participants
Race (NIH/OMB)
Black or African American
7 Participants3 Participants10 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
40 Participants42 Participants82 Participants
Region of Enrollment
United States
54 participants54 participants108 participants
Sex: Female, Male
Female
43 Participants42 Participants85 Participants
Sex: Female, Male
Male
11 Participants12 Participants23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 600 / 60
other
Total, other adverse events
0 / 600 / 60
serious
Total, serious adverse events
0 / 600 / 60

Outcome results

Primary

Requests for a COVID-19 Vaccine Resource Sheet

Whether or not the participant requested that our study team send them an electronic resource sheet on the COVID-19 vaccine and where they can get vaccinated.

Time frame: 1 time request during the 4-week study

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
HOPE InterventionRequests for a COVID-19 Vaccine Resource Sheet6 Participants
ControlRequests for a COVID-19 Vaccine Resource Sheet0 Participants
Secondary

Proof of COVID-19 Vaccination

Whether or not a participant sent us a proof of a COVID-19 Vaccination

Time frame: 1 time proof during 4-week study and up to 2 weeks after

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
HOPE InterventionProof of COVID-19 Vaccination10 Participants
ControlProof of COVID-19 Vaccination6 Participants

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026